Literature DB >> 21134366

Chemokines in cancer related inflammation.

Paola Allavena1, Giovanni Germano, Federica Marchesi, Alberto Mantovani.   

Abstract

Chemokines are key players of the cancer-related inflammation. Chemokine ligands and receptors are downstream of genetic events that cause neoplastic transformation and are abundantly expressed in chronic inflammatory conditions which predispose to cancer. Components of the chemokine system affect multiple pathways of tumor progression including: leukocyte recruitment, neo-angiogenesis, tumor cell proliferation and survival, invasion and metastasis. Evidence in pre-clinical and clinical settings suggests that the chemokine system represents a valuable target for the development of innovative therapeutic strategies.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134366     DOI: 10.1016/j.yexcr.2010.11.013

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  80 in total

Review 1.  Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Drugs       Date:  2017-06       Impact factor: 9.546

2.  Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.

Authors:  Liang Ding; Bing Li; Ying Zhao; Yi-Fu Fu; Er-Ling Hu; Qin-Gang Hu; Yan-Hong Ni; Ya-Yi Hou
Journal:  Tumour Biol       Date:  2014-07-25

Review 3.  The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.

Authors:  Sandra M Cardona; Jenny A Garcia; Astrid E Cardona
Journal:  Methods Mol Biol       Date:  2013

4.  Priming cancer cells for drug resistance: role of the fibroblast niche.

Authors:  Wei Bin Fang; Min Yao; Nikki Cheng
Journal:  Front Biol (Beijing)       Date:  2014-02-01

Review 5.  Modeling tumor microenvironments in vitro.

Authors:  Mingming Wu; Melody A Swartz
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

Review 6.  Skewed Signaling through the Receptor for Advanced Glycation End-Products Alters the Proinflammatory Profile of Tumor-Associated Macrophages.

Authors:  Armando Rojas; Paulina Araya; Jacqueline Romero; Fernando Delgado-López; Ileana Gonzalez; Carolina Añazco; Ramon Perez-Castro
Journal:  Cancer Microenviron       Date:  2018-08-08

Review 7.  Inflammation and prostate cancer: friends or foe?

Authors:  Gianluigi Taverna; Elisa Pedretti; Giuseppe Di Caro; Elena Monica Borroni; Federica Marchesi; Fabio Grizzi
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

Review 8.  The role of the mediators of inflammation in cancer development.

Authors:  José Veríssimo Fernandes; Ricardo Ney Oliveira Cobucci; Carlos André Nunes Jatobá; Thales Allyrio Araújo de Medeiros Fernandes; Judson Welber Veríssimo de Azevedo; Josélio Maria Galvão de Araújo
Journal:  Pathol Oncol Res       Date:  2015-03-05       Impact factor: 3.201

9.  Neurotensin/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells.

Authors:  Pei Xiao; Xinxin Long; Lijie Zhang; Yingnan Ye; Jincheng Guo; Pengpeng Liu; Rui Zhang; Junya Ning; Wenwen Yu; Feng Wei; Jinpu Yu
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

10.  The role of CXCL chemokine family in the development and progression of gastric cancer.

Authors:  Xuyan Chen; Renpin Chen; Ruifang Jin; Zhiming Huang
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.